Review Article
Volume 3 Issue 6 - 2020
The Epidemiology Study on Ebola Virus and its Complete Treatment; A Narrative Review
Gulafsha Fatima1*, Nazima Fatima1, Noor US Sabah1, Mohammad Gayoor Khan2, Umama Yezdani1, Karthikeyan Lakshmanan3, Hari Baskar4, Mukilan D5 and Shareefa Habeeba1
1Department of Pharmacy Practice, MRM College of Pharmacy, Hyderabad, Telangana, India
2Department of Pharmacy, Truba Institute of Pharmacy, Bhopal, Madhya Pradesh, India
3Department of Pharmaceutical Chemistry, College of Pharmacy, Madras Medical College, Chennai, Tamil Nadu, India
4Department of Pharmacy, KMCH College of Pharmacy, Coimbatore, Tamil Nadu, India
5Department of Pharmacy Practice, Vels Institute of Science Technology and Advanced Studies, Chennai, Tamil Nadu, India
*Corresponding Author: Gulafsha Fatima, Department of Pharmacy Practice, MRM College of Pharmacy, Hyderabad, Telangana, India.
Received: April 29, 2020; Published: May 07, 2020




Abstract

According to WHO Ebola virus is also considered a Pandemic for South African region, this virus is life-threatening even mortal rate 50% if a person suffering from Ebola 50% chances to cure it expand very fast in South African region, EVD (Ebola Virus Disease) first time is shown in the 1970s in Zaire from 35 - 87% it expands to till 2018. The Republic of Congo is reported firstly. Then after 2018 till most region it expands especially in Central Africa region including Sudan, Uganda even more than 63k cases till now registered Ebola is a second most dangerous disease after covid19 because Pandemic corona virus target all over world Ebola is serious after covid19 for Ebola virus favipiravir drug is very familiar and 4th phase clinical trial is passed this drug is designed by Japan. In this review, we are elaborating on epidemiology, treatment, management of Ebola virus disease EVD.

Keywords: Ebola Virus; Epidemiology; World Health Organization; Central Africa; Japan; Infectious Disease

References

  1. Lo TQ., et al. “Ebola: anatomy of an epidemic”. The Annual Review of Medicine 68 (2017): 359-370.
  2. Garske T., et al. “Heterogeneities in the case fatality ratio in the West African Ebola outbreak 2013-2016”. Philosophical Transactions of the Royal Society B: Biological Sciences 372 (2017): 20160308.
  3. Bukreyev AA., et al. “Discussions and decisions of the 2012-2014 International Committee on Taxonomy of Viruses (ICTV) Filoviridae Study Group, January 2012-June 2013”. Archives of Virology 159 (2014): 821-830.
  4. Centers for Disease Control and Prevention. “Ebola virus disease distribution map: cases of Ebola virus disease in Africa since” (1976).
  5. Holmes EC., et al. “The evolution of Ebola virus: insights from the 2013-2016 epidemic”. Nature 538 (2016): 193-200.
  6. Dudas G., et al. “Virus genomes reveal factors that spread and sustained the Ebola epidemic”. Nature 544 (2017): 309-315.
  7. Hoenen T., et al. “Virology. Mutation rate and genotype variation of Ebola virus from Mali case sequences”. Science 348 (2015): 117-119.
  8. Diehl WE., et al. “Ebola virus glycoprotein with increased infectivity dominated the 2013-2016 epidemic”. Cell 167 (2016): 1088-98.e6.
  9. Urbanowicz RA., et al. “Human adaptation of Ebola virus during the West African outbreak”. Cell 167 (2016): 1079-87.e5.
  10. Wang MK., et al. “Biochemical basis for increased activity of Ebola glycoprotein in the 2013-16 epidemic”. Cell Host Microbe 21 (2017): 367-375.
  11. Marzi A., et al. “Recently identified mutations in the Ebola virus-makona genome do not alter pathogenicity in animal models”. Cell Reports 23 (2018): 1806-1816.
  12. Briand S., et al. “The international Ebola emergency”. The New England Journal of Medicine 371 (2014): 1180-1183.
  13. Mbala Kingebeni P., et al. “Rapid confirmation of the Zaire Ebola virus in the outbreak of the Equateur province in the Democratic Republic of Congo: implications for public health interventions”. Clinical Infectious Diseases 68 (2019): 330-333.
  14. Ebola Outbreak Epidemiology Team. “Outbreak of Ebola virus disease in the Democratic Republic of the Congo, April-May, 2018: an epidemiological study”. Lancet 392 (2018): 213-221.
  15. Houlihan CF., et al. “Ebola exposure, illness experience, and Ebola antibody prevalence in international responders to the west African Ebola epidemic 2014-2016: a cross-sectional study”. PLOS Medicine 14 (2017): e1002300.
  16. Bogoch II., et al. “Assessment of the potential for international dissemination of Ebola virus via commercial air travel during the 2014 west African outbreak”. Lancet 385 (2015): 29-35.
  17. Parra JM., et al. “The first case of Ebola virus disease acquired outside Africa”. The New England Journal of Medicine 371 (2014): 2439-2440.
  18. Liddell AM., et al. “Characteristics and clinical management of a cluster of 3 patients with Ebola virus disease, including the first domestically acquired cases in the United States”. Annals of Internal Medicine 163 (2015): 81-90.
  19. Jacobs M., et al. “Late Ebola virus relapse causing meningoencephalitis: a case report”. Lancet 388 (2016): 498-503.
  20. Mohd Gayoor Khan. “The Novel Drug Delivery System”. World Journal of Pharmacy and Pharmaceutical Sciences 7 (2017): 477-487.
  21. Mate SE., et al. “Molecular evidence of sexual transmission of Ebola virus”. The New England Journal of Medicine 373 (2015): 2448-54.
  22. Diallo B., et al. “Resurgence of Ebola virus disease in Guinea linked to a survivor with virus persistence in seminal fluid for more than 500 days”. Clinical Infectious Diseases 63 (2016): 1353-1356.
  23. Bower H and Glynn JR. “A systematic review and meta-analysis of seroprevalence surveys of Ebola virus infection”. Scientific Data 4 (2017): 160133.
  24. Hira S and Piot P. “The counter effects of the Ebola epidemic on control and treatment of HIV/AIDS, tuberculosis, and malaria in west Africa”. AIDS 30 (2016): 2555-2559.
  25. Parpia AS., et al. “Effects of response to 2014-2015 Ebola outbreak on deaths from malaria, HIV/AIDS, and tuberculosis, west Africa”. Emerging Infectious Diseases 22 (2016): 433-441.
  26. Bekolo CE., et al. “Six-monthly appointment spacing for clinical visits as a model for retention in HIV care in Conakry-Guinea: a cohort study”. BMC Infectious Diseases 17 (2017): 766.
  27. Tattevin P., et al. “Retention in care for HIV-infected patients in the eye of the Ebola storm: lessons from Monrovia, Liberia”. AIDS 29 (2015): N1-N2.
  28. Aregawi M., et al. “Impact of the mass drug administration for malaria in response to the Ebola outbreak in Sierra Leone”. Malaria Journal 15 (2016): 480.
  29. Plucinski MM., et al. “Effect of the Ebola-virus-disease epidemic on malaria case management in Guinea, 2014: a cross-sectional survey of health facilities”. The Lancet Infectious Diseases 15 (2015): 1017-1023.
  30. Ansumana R., et al. “Impact of infectious disease epidemics on tuberculosis diagnostic, management, and prevention services: experiences and lessons from the 2014-2015 Ebola virus disease outbreak in west Africa”. International Journal of Infectious Diseases 56 (2017): 101-104.
Citation: Gulafsha Fatima., et al. “The Epidemiology Study on Ebola Virus and its Complete Treatment; A Narrative Review”. EC Clinical and Medical Case Reports 3.6 (2020): 33-39.

PubMed Indexed Article


EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005


EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777


EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347


EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478


EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253


EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033


EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992


EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505


EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793


EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211


EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047


EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560


EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318


EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819


EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840


EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344


EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476


EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658


EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489


EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278


EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108


EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571


EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333


EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883


EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001


EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937


EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723


EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726


EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603


EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646


EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616


EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290


EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226


EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812


EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268


News and Events


April Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the April issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for upcoming Issue

Ecronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before April 26, 2021.

Certificate of Publication

Ecronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

Ecronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.

Immediate Assistance

The prime motto of this team is to clarify all the queries without any delay or hesitation to avoid the inconvenience. For immediate assistance on your queries please don't hesitate to drop an email to editor@ecronicon.uk